# A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn

> **NCT00627016** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 305 (actual)

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Dexlansoprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00627016
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627016, "A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00627016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*